Logo image of MRM

MEDIROM HEALTHCARE TECHNOLOG (MRM) Stock Fundamental Analysis

NASDAQ:MRM - US58510H1032 - ADR

1.97 USD
+0.06 (+3.14%)
Last: 8/27/2025, 8:05:40 PM
1.91 USD
-0.06 (-3.05%)
Pre-Market: 8/28/2025, 8:08:57 AM
Fundamental Rating

2

Taking everything into account, MRM scores 2 out of 10 in our fundamental rating. MRM was compared to 71 industry peers in the Diversified Consumer Services industry. MRM may be in some trouble as it scores bad on both profitability and health. MRM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year MRM has reported negative net income.
MRM had a negative operating cash flow in the past year.
In multiple years MRM reported negative net income over the last 5 years.
MRM had a negative operating cash flow in each of the past 5 years.
MRM Yearly Net Income VS EBIT VS OCF VS FCFMRM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B

1.2 Ratios

With a Return On Assets value of 1.84%, MRM perfoms like the industry average, outperforming 54.93% of the companies in the same industry.
MRM has a better Return On Equity (15.97%) than 80.28% of its industry peers.
MRM has a Return On Invested Capital of 0.09%. This is comparable to the rest of the industry: MRM outperforms 53.52% of its industry peers.
Industry RankSector Rank
ROA 1.84%
ROE 15.97%
ROIC 0.09%
ROA(3y)1.91%
ROA(5y)-4.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MRM Yearly ROA, ROE, ROICMRM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

MRM's Profit Margin of 1.80% is in line compared to the rest of the industry. MRM outperforms 52.11% of its industry peers.
MRM's Profit Margin has improved in the last couple of years.
The Operating Margin of MRM (0.06%) is comparable to the rest of the industry.
MRM's Operating Margin has declined in the last couple of years.
MRM's Gross Margin of 27.06% is on the low side compared to the rest of the industry. MRM is outperformed by 67.61% of its industry peers.
In the last couple of years the Gross Margin of MRM has grown nicely.
Industry RankSector Rank
OM 0.06%
PM (TTM) 1.8%
GM 27.06%
OM growth 3YN/A
OM growth 5Y-50.46%
PM growth 3YN/A
PM growth 5Y32.32%
GM growth 3Y1.13%
GM growth 5Y2.15%
MRM Yearly Profit, Operating, Gross MarginsMRM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

More info and screens

0

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MRM is destroying value.
MRM has more shares outstanding than it did 1 year ago.
MRM has more shares outstanding than it did 5 years ago.
The debt/assets ratio for MRM is higher compared to a year ago.
MRM Yearly Shares OutstandingMRM Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
MRM Yearly Total Debt VS Total AssetsMRM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

MRM has an Altman-Z score of 1.04. This is a bad value and indicates that MRM is not financially healthy and even has some risk of bankruptcy.
MRM has a Altman-Z score (1.04) which is in line with its industry peers.
MRM has a Debt/Equity ratio of 1.35. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.35, MRM is not doing good in the industry: 70.42% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Altman-Z 1.04
ROIC/WACC0.04
WACC2.31%
MRM Yearly LT Debt VS Equity VS FCFMRM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

2.3 Liquidity

A Current Ratio of 0.65 indicates that MRM may have some problems paying its short term obligations.
The Current ratio of MRM (0.65) is worse than 74.65% of its industry peers.
A Quick Ratio of 0.61 indicates that MRM may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.61, MRM is doing worse than 74.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.65
Quick Ratio 0.61
MRM Yearly Current Assets VS Current LiabilitesMRM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for MRM have decreased strongly by -180.65% in the last year.
Measured over the past years, MRM shows a very strong growth in Earnings Per Share. The EPS has been growing by 47.97% on average per year.
Looking at the last year, MRM shows a very strong growth in Revenue. The Revenue has grown by 21.54%.
The Revenue has been growing by 16.25% on average over the past years. This is quite good.
EPS 1Y (TTM)-180.65%
EPS 3YN/A
EPS 5Y47.97%
EPS Q2Q%24.84%
Revenue 1Y (TTM)21.54%
Revenue growth 3Y15.33%
Revenue growth 5Y16.25%
Sales Q2Q%34.55%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MRM Yearly Revenue VS EstimatesMRM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MRM. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MRM Price Earnings VS Forward Price EarningsMRM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

61.97% of the companies in the same industry are more expensive than MRM, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.51
MRM Per share dataMRM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MRM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MEDIROM HEALTHCARE TECHNOLOG

NASDAQ:MRM (8/27/2025, 8:05:40 PM)

Premarket: 1.91 -0.06 (-3.05%)

1.97

+0.06 (+3.14%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)05-20 2025-05-20
Earnings (Next)N/A N/A
Inst Owners4.05%
Inst Owner Change-59.55%
Ins Owners25.57%
Ins Owner ChangeN/A
Market Cap15.57M
Analysts0
Price TargetN/A
Short Float %0.07%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.28
P/FCF N/A
P/OCF N/A
P/B 2.47
P/tB N/A
EV/EBITDA 12.51
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.62
FCFYN/A
OCF(TTM)-1.14
OCFYN/A
SpS7.09
BVpS0.8
TBVpS-0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.84%
ROE 15.97%
ROCE 0.13%
ROIC 0.09%
ROICexc 0.09%
ROICexgc 0.14%
OM 0.06%
PM (TTM) 1.8%
GM 27.06%
FCFM N/A
ROA(3y)1.91%
ROA(5y)-4.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-46.41%
ROICexc growth 3YN/A
ROICexc growth 5Y-50.04%
OM growth 3YN/A
OM growth 5Y-50.46%
PM growth 3YN/A
PM growth 5Y32.32%
GM growth 3Y1.13%
GM growth 5Y2.15%
F-Score6
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Debt/EBITDA 4.26
Cap/Depr 194.83%
Cap/Sales 6.81%
Interest Coverage 0.1
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.65
Quick Ratio 0.61
Altman-Z 1.04
F-Score6
WACC2.31%
ROIC/WACC0.04
Cap/Depr(3y)216.57%
Cap/Depr(5y)157.79%
Cap/Sales(3y)7.57%
Cap/Sales(5y)5.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-180.65%
EPS 3YN/A
EPS 5Y47.97%
EPS Q2Q%24.84%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21.54%
Revenue growth 3Y15.33%
Revenue growth 5Y16.25%
Sales Q2Q%34.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y101.09%
EBIT growth 3YN/A
EBIT growth 5Y-42.41%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-110.76%
OCF growth 3YN/A
OCF growth 5YN/A